Jackson Acquisition Co II
| IPO Proceeds, $M | $230.00M |
|---|---|
| IPO Date | Dec 10, 2024 |
| CEO | Richard L. Jackson |
| Left Lead | Roth Capital Partners |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Healthcare services, healthcare technology, or otherwise focused on the healthcare industry |
| IPO Geography | Global |
| Target Company | TBD |
| Deal Announced | TBD |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
No credit card required
Sign in for more on Jackson Acquisition Co II:
- Structure and cap table
- 6 directors & officers
- 6 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Richard L. Jackson | 70 | Chief Executive Officer, Director |
| David Lawrence | 67 | Chief Financial Officer |
| Brian A. McCarthy | 65 | Director |
| J. Nicholas Ayers | 42 | Director |
| Stephan S. Rodgers | 63 | Director |
| Paul G. Gabos | 59 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
| Roth Capital Partners | BR | 17,000,000 | units |
| Craig-Hallum Capital Group | 3,000,000 | ||
| 20,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
2.00 | % |
Sign in to view more advisor data.
Filings
| Sep 27, 2024 | Initial S-1 |
| Nov 25, 2024 |
Amended S-1
Sign In to view filing content. |
| Dec 6, 2024 |
Amended S-1
Sign In to view filing content. |
| Dec 9, 2024 |
PR announcing pricing of $200mm IPO
Sign In to view filing content. |
| Dec 11, 2024 |
424B4 IPO Prospectus
Sign In to view filing content. |
| Dec 11, 2024 |
8-K announcing full over-allotment exercise
Sign In to view filing content. |